Related Experiment Video
Updated: Jun 28, 2025

10:10
Reverse Total Shoulder Arthroplasty
Published on: July 5, 2011
43.2K
Glenosphere Size Does Not Matter in Reverse Total Shoulder Arthroplasty
Akshar V Patel1, Christopher A White1, Troy Li1
1Departamento de Cirurgia Ortopédica, Icahn School of Medicine at Mount Sinai, New York City, New York, Estados Unidos.
Revista Brasileira De Ortopedia
|April 12, 2024
Summary
Reverse total shoulder arthroplasty (TSA) offers improved shoulder function and range of motion. Glenosphere size (36mm vs. 40mm) did not significantly impact postoperative outcomes in this study.
Area of Science:
- Orthopedic Surgery
- Biomedical Engineering
- Musculoskeletal Research
Background:
- Reverse total shoulder arthroplasty (TSA) is a common procedure for complex shoulder conditions.
- Limited data exists on the impact of glenosphere size on reverse TSA outcomes.
- Understanding glenosphere size influence is crucial for optimizing surgical results.
Purpose of the Study:
- To investigate the effect of glenosphere size (36mm vs. 40mm) on postoperative outcomes after reverse TSA.
- To compare range of motion, patient-reported outcomes, and radiographic variables between different glenosphere sizes.
Main Methods:
- Retrospective analysis of patients undergoing reverse TSA with a minimum 2-year follow-up.
- Patients stratified into 36mm and 40mm glenosphere size cohorts.
- Evaluation of range of motion, ASES, VAS pain, and SST scores; assessment of scapular notching and loosening.
Main Results:
- Significant improvements in range of motion (except internal rotation) observed in both cohorts.
- No significant differences in postoperative range of motion, ASES, or VAS pain scores between 36mm and 40mm groups.
- Forward elevation: 134° (36mm) vs. 133° (40mm); External rotation: 37° (36mm) vs. 35° (40mm).
Conclusions:
- Reverse TSA yields consistent improvements in shoulder function and range of motion regardless of glenosphere size.
- Glenosphere size does not appear to be a critical factor in short-to-mid-term reverse TSA outcomes.
- Further research may explore long-term effects and specific patient subgroups.

